#United States #Medical Devices #Franklin #Healthcare Innovation #Amsino International

Amsino Expands U.S. Manufacturing with New Facility in Boston

Amsino International has recently made a significant advancement in its goal to improve healthcare on a global scale by establishing a new manufacturing, research, and development facility in Franklin, Massachusetts, aptly named Amsino Scientific Inc. This major expansion signifies a pivotal moment in Amsino’s ongoing growth and represents the company’s strong pledge to deliver innovative, dependably produced, cost-effective, and user-friendly medical devices.

The new Boston Site will primarily focus on the manufacturing and development of the Sentinel Enteral Feeding Pump, a product line recently acquired from Alcor Scientific, Inc. This expansion is not just about increasing production; it also aims to enhance the quality of products and foster continuous innovation through robust research and development operations housed within the facility.

Dr. Richard Y. Lee, who serves as Chairman and CEO of Amsino International, emphasized the importance of this new facility during the announcement. He remarked, “This strengthens our manufacturing capabilities in the United States and reinforces our dedication to providing high-quality, life-enhancing medical devices to patients and healthcare providers around the world.”

The operational leadership of the Boston Site will lie with Dr. Mei Zhang, the Vice President of Engineering at Amsino International. Dr. Zhang acknowledges the collective mission of their team, stating, “At the heart of our team is a shared mission to manufacture innovative and reliable solutions to improve safety and effectiveness of patient care. Every device we manufacture, every system we optimize, moves us closer to our goal—to advance healthcare worldwide.”

To commemorate the opening of this state-of-the-art facility, a ribbon-cutting ceremony was held on April 4, 2025. This event marks the dawn of a new chapter for Amsino, further solidifying its commitment to enhancing health and life through excellence in medical device manufacturing. The Boston Site is set to play a vital role in expanding the company’s product offerings and improving patient care standards.

As Amsino continues its trajectory of growth, the establishment of this new facility represents a significant investment not only in the company’s capabilities but also in the future of medical care in the United States. The combination of advanced manufacturing processes and innovative product developments promises a new era of excellence in healthcare solutions.

In summary, Amsino's recent expansion demonstrates not only its ambition to grow as a leading manufacturer of medical devices but also highlights its commitment to improving healthcare delivery and patient outcomes globally. This strategic move is expected to pave the way for new innovations and efficiencies that will benefit healthcare providers and patients alike in the years to come.